Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gwang Ha Kim

Showing results (321-330 of 332) with videos related to

Pageof 34
Sort By:
Helicobacter|August 2, 2019
Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication successBeom Jin Kim, Chang-Hun Yang, Hyun Joo Song, et al.
Gut and Liver|February 15, 2023
Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic GastritisGwang Ha Kim, Myung-Gyu Choi, Jin Il Kim, et al.
World Journal of Gastroenterology|December 12, 2022
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitisKang Nyeong Lee, Oh Young Lee, Hoon Jai Chun, et al.
Gut and Liver|April 8, 2021
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 StudyGwang Ha Kim, Hang Lak Lee, Moon Kyung Joo, et al.
Gut and Liver|June 13, 2023
Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 studyJie-Hyun Kim, Hwoon-Yong Jung, In Kyung Yoo, et al.
Gut and Liver|April 28, 2025
Korean Registry on the Current Management of <i>Helicobacter pylori</i> (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line TreatmentHyo-Joon Yang, Joon Sung Kim, Ji Yong Ahn, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|December 26, 2024
Position statement of the World Endoscopy Organization: Role of endoscopy in screening, diagnosis, and treatment of esophageal superficial squamous neoplasiaiaCesare Hassan, Giulio Antonelli, Philip Wai-Yan Chiu, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.
Gut and Liver|February 8, 2018
Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) StudyJoon Sung Kim, Byung-Wook Kim, Sung Min Park, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2019
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisKwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, et al.
Pageof 34

Showing results (321-330 of 332) with videos related to

Sort By:
Pageof 34
Helicobacter|August 2, 2019
Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication successBeom Jin Kim, Chang-Hun Yang, Hyun Joo Song, et al.
Gut and Liver|February 15, 2023
Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic GastritisGwang Ha Kim, Myung-Gyu Choi, Jin Il Kim, et al.
World Journal of Gastroenterology|December 12, 2022
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitisKang Nyeong Lee, Oh Young Lee, Hoon Jai Chun, et al.
Gut and Liver|April 8, 2021
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 StudyGwang Ha Kim, Hang Lak Lee, Moon Kyung Joo, et al.
Gut and Liver|June 13, 2023
Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 studyJie-Hyun Kim, Hwoon-Yong Jung, In Kyung Yoo, et al.
Gut and Liver|April 28, 2025
Korean Registry on the Current Management of <i>Helicobacter pylori</i> (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line TreatmentHyo-Joon Yang, Joon Sung Kim, Ji Yong Ahn, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|December 26, 2024
Position statement of the World Endoscopy Organization: Role of endoscopy in screening, diagnosis, and treatment of esophageal superficial squamous neoplasiaiaCesare Hassan, Giulio Antonelli, Philip Wai-Yan Chiu, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.
Gut and Liver|February 8, 2018
Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) StudyJoon Sung Kim, Byung-Wook Kim, Sung Min Park, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2019
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisKwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, et al.
Pageof 34